Tarsier Pharma Ltd. (TARX)

Tarsier Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2025	Dec 31, 2024
Debt / Equity Ratio	-1.33	-1.33	-1.30
Debt / EBITDA Ratio	0.87	0.87	1.43
Debt / FCF Ratio	-5.02	-5.02	-1.88
Net Debt / Equity Ratio	-0.93	-0.93	-0.86
Net Debt / EBITDA Ratio	0.61	0.61	0.94
Net Debt / FCF Ratio	-3.50	-3.50	-1.24
Quick Ratio	2.46	2.46	2.17
Interest Coverage	3.02	3.02	43.34
Return on Equity (ROE)	-101.58%	-101.58%	-88.82%
Return on Assets (ROA)	218.06%	218.06%	190.83%
Return on Capital Employed (ROCE)	501.39%	501.39%	346.28%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).